Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

coronavirus

Sona Nanotech & GE Health Life Sciences partnership

Sona partners with GE Healthcare Life Sciences to complete Coronavirus Rapid Screening Test

Halifax, Nova Scotia, March 3, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences’ … Read More

Bond Digital Health & Sona Nanotech

Sona Announces Data Partnership for Covid-19 Rapid Screening Test

Halifax, Nova Scotia, February 18, 2020 – Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology company Bond Digital Health (Bond) to add data capture and analysis to its coronavirus (Covid-19) rapid screening test currently in … Read More

Sona Develops Rapid Screening Test for Coronavirus

  HALIFAX, Feb 10, 2020 — Sona Nanotech Inc. (“Sona”) (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, “nCoV19”. Sona is developing a quick-response lateral-flow test to screen patients … Read More

NativeAntigen & Sona Nanotech

Sona announces key partner for Coronavirus Rapid Screening Test

Halifax, Nova Scotia, Feb. 13, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) has secured an agreement with The Native Antigen Company (“Native”) to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona … Read More